Thiyagaraja Ravindran
Direktor/Vorstandsmitglied bei UCB Fipar SA
Profil
Thiyagaraja Ravindran is currently a Director at UCB Fipar SA since 2018.
Prior to this, he worked as a Director at Zogenix, Inc.
Aktive Positionen von Thiyagaraja Ravindran
| Unternehmen | Position | Beginn |
|---|---|---|
UCB Fipar SA
 UCB Fipar SA Financial ConglomeratesFinance Part of UCB SA, UCB Fipar SA is an investment holding Belgian company. The company is based in Anderlecht, Belgium. UCB Fipar was founded in 1947. | Direktor/Vorstandsmitglied | 09.02.2018 |
Ehemalige bekannte Positionen von Thiyagaraja Ravindran
| Unternehmen | Position | Ende |
|---|---|---|
| ZOGENIX, INC. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
UCB Fipar SA
UCB Fipar SA Financial ConglomeratesFinance Part of UCB SA, UCB Fipar SA is an investment holding Belgian company. The company is based in Anderlecht, Belgium. UCB Fipar was founded in 1947. | Finance |
Zogenix, Inc.
 Zogenix, Inc. Pharmaceuticals: MajorHealth Technology Zogenix, Inc. is a pharmaceutical company. The firm engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. Its products include Fintepla and MT1621. The company was founded by Stephen James Farr, Cam L. Garner, Roger L. Hawley, Bret E. Megargel, Jonathan M. N. Rigby, Scott L. Glenn, and John J. Turanin on May 11, 2006 and is headquartered in Emeryville, CA. | Health Technology |
